Hormone Replacement Therapy
-
Subject Areas on Research
- A pooled multisite analysis of the effects of female reproductive hormones on glioma risk.
- A systematic review of persistence and compliance with bisphosphonates for osteoporosis.
- A tailored intervention to aid decision-making about hormone replacement therapy.
- Acquired thrombotic risk factors in the critical care setting.
- Advances in primary stroke prevention.
- Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
- Antiresorptive pharmacotherapy in older women: where the evidence-based medicine rubber meets the geriatrics road.
- Ascorbic acid status in postmenopausal women with hormone replacement therapy.
- Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial.
- Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy.
- Best Practices in Transgender Health: A Clinician's Guide.
- Breast cancer: hormones and other risk factors.
- Coping styles and personality domains related to menopausal stress.
- Diagnosis and treatment of hypothyroidism in the elderly.
- Differences in the apparent metabolic clearance rate of testosterone in young and older men with gonadotropin suppression receiving graded doses of testosterone.
- Does hormone replacement therapy influence retinal microvascular caliber?
- Estradiol replacement therapy regulates innate immune response in ovariectomized arthritic mice.
- Female reproductive factors and major eye diseases in Asian women -the Singapore Malay Eye Study.
- Fibroblast growth factor 21 and thyroid hormone show mutual regulatory dependency but have independent actions in vivo.
- Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.
- Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial.
- Hormone replacement therapy and reduced cognitive decline in older women: the Cache County Study.
- Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis.
- Impact of hormone replacement therapy on exercise training-induced improvements in insulin action in sedentary overweight adults.
- Lessons From the Testosterone Trials.
- Male and Female Hypogonadism.
- Mammographic density: intersection of science, the law, and clinical practice.
- Management of Menopausal Symptoms for Women Who Are at High Risk of Thrombosis.
- Managing menopause.
- Markers of Iron Flux during Testosterone-Mediated Erythropoiesis in Older Men with Unexplained or Iron-Deficiency Anemia.
- Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.
- Menopausal hormone therapy use and long-term all-cause and cause-specific mortality in the Long Island Breast Cancer Study Project.
- Menopausal hormones and breast cancer in a biracial population.
- Menopausal hormones and risk of ovarian cancer.
- Meta-analyses of colorectal cancer risk factors.
- Not ready for prime time.
- Outcome of lower extremity revascularization for peripheral artery occlusive disease: is there a difference between men and women?
- Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer.
- Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ.
- Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.
- Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease.
- Prader Willi Syndrome: Genetics, Metabolomics, Hormonal Function, and New Approaches to Therapy.
- Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women.
- Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.
- Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.
- Promoting informed decision making: hormone replacement therapy.
- Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
- Racial differences in physician recommendation of hormone replacement therapy.
- Radiation-associated breast cancer and gonadal hormone exposure: a report from the Childhood Cancer Survivor Study.
- Reduced fracture rates observed only in patients with proper persistence and compliance with bisphosphonate therapies.
- Response of high-sensitivity C-reactive protein to exercise training in an at-risk population.
- Risk factors for estrogen receptor-positive breast cancer.
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Targeting risk factors for reducing the racially disparate burden in breast cancer.
- Testosterone supplementation for hypoactive sexual desire disorder in women.
- Type and duration of exogenous hormone use affects breast cancer histology.
- Uterine Neoplasms. Clinical Practice Guidelines in Oncology.
- Women's willingness to accept perceived risks for vasomotor symptom relief.
-
Keywords of People
- Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
- Grambow, Steven C., Assistant Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics
- Moorman, Patricia Gripka, Professor in Family Medicine and Community Health, Duke Cancer Institute